
Medical Disclaimer | This article is for informational and educational purposes only and does not constitute medical advice. The content on this page has not been evaluated by the Food and Drug Administration (FDA). PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Always consult a qualified healthcare provider before starting any new supplement, especially if you take prescription medications or have a medical condition. Individual results may vary.
Valerian root has been used as a sleep aid for over 2,000 years. CBD has been used for sleep for roughly a decade. Both show up in the 'natural sleep supplement' category — but they work through fundamentally different mechanisms, carry different side effect profiles, and are best suited to different types of insomnia.
Unlike our CBD vs. Magnesium or CBD vs. Ashwagandha comparisons, this one has a clearer winner in most scenarios: CBD's evidence is more consistent and its side effect profile is cleaner. But valerian has a specific role for a specific sleep pattern where it genuinely adds something CBD doesn't provide as directly. This guide maps that out precisely.
For the full CBD sleep science, seeCBD for Sleep: The Ultimate 2026 Guide. For the magnesium comparison, seeCBD vs. Magnesium for Sleep.
Valerian (Valeriana officinalis) contains several active compounds — most notably valerenic acid, isovaleric acid, and various iridoids — that produce sleep-promoting effects through multiple mechanisms:
Key characteristics:Valerian is genuinely sedating — it directly increases GABA activity rather than removing anxiety barriers to sleep. This makes it more useful for people who need a mild sedative nudge toward sleep onset, and less useful for people whose insomnia is primarily anxiety-driven.
CBD's sleep mechanism is covered in depth in ourCBD for Sleep guide. The key distinction from valerian: CBD doesn't directly sedate — it removes the barriers to sleep.
Valerian's clinical evidence is more mixed than its reputation suggests. A2006 meta-analysis in the American Journal of Medicine examined 16 RCTs of valerian for sleep and concluded that it may improve sleep quality without producing side effects — but noted that the evidence was not sufficient to confirm efficacy definitively due to methodological heterogeneity across studies. More recent trials have been more positive: a2022 systematic review in Sleep Medicine Reviews found that valerian significantly reduced sleep onset latency and improved subjective sleep quality across included trials, with a favorable safety profile.
The honest assessment of valerian evidence: it works for a meaningful proportion of users, particularly for sleep onset. But trial results are inconsistent — likely because valerian is most effective for a specific type of insomnia (GABA-deficit primary sleep onset difficulty) and less effective for anxiety-driven or pain-driven insomnia. When studies mix these populations, the average effect size appears modest.
CBD's sleep evidence is more consistent partly because its primary mechanism — anxiety reduction — is a driver of insomnia in a large proportion of the general population. The2019 Permanente Journal case series found 66.7% of patients improved sleep scores within one month. The broad anxiolytic evidence — including the 2011 Neuropsychopharmacology RCT and the 2019 Neurotherapeutics review — translates directly to CBD's sleep benefit for the majority of sleep-disrupted adults whose insomnia has an anxiety component.
Grogginess and next-morning function:This is one of CBD's clearest advantages over valerian. Valerian's GABA-enhancing sedation can leave some users with next-day grogginess or brain fog — particularly at higher doses. CBD at typical wellness doses does not produce this effect. For people who need to be cognitively sharp in the morning, CBD is the preferable choice.
|
|
CBD |
Valerian Root |
CBD + Valerian |
|
Primary mechanism |
5-HT1A agonism; HPA cortisol blunting; ECS tone; CB1 in sleep circuits |
GABA-A agonism and reuptake inhibition; adenosine receptor activity; serotonin modulation |
Complementary — ECS/serotonin + GABA/adenosine |
|
Sleep onset |
✓ Strong — reduces anxiety-driven delay |
✓ Moderate — direct sedative via GABA |
✓✓ Combined covers both drivers |
|
Sleep quality / depth |
Moderate — CBN addition enhances |
Moderate — GABA promotes slow-wave onset |
✓ Both contribute to deeper sleep |
|
Next-day grogginess |
None at typical doses |
Possible — especially at higher doses or in sensitive users |
Risk from valerian; CBD does not add grogginess |
|
Dependency / tolerance |
None documented |
Mild — some tolerance with nightly use; avoid abrupt discontinuation after prolonged high-dose use |
CBD carries no added dependency risk |
|
Anxiety component |
✓✓ Strong — primary CBD advantage |
Mild — GABA activity reduces anxiety indirectly |
CBD leads on anxiety relief |
|
Pain-disrupted sleep |
✓ Strong — analgesic + anti-inflammatory |
Not applicable |
CBD essential for this use case |
|
Onset time |
30–60 min (sublingual oil); 45–90 min (gummies) |
30–120 min — highly variable |
Similar window; stack together |
|
Next-morning clarity |
✓ Full cognitive clarity typical |
Variable — some users report brain fog |
CBD may offset valerian grogginess |
|
Safety / side effects |
Excellent — WHO confirmed |
Generally safe; GI upset in some; avoid in pregnancy; avoid with sedatives |
Review sedative medication interactions |
|
Drug interactions |
CYP450 inhibition at higher doses |
CYP3A4 substrate; sedative drug interactions (benzodiazepines, alcohol) |
Both may amplify sedatives — use with caution |
|
Evidence quality |
Strong — human RCT data for anxiety-driven sleep |
Moderate — mixed clinical trials; some high-quality RCTs |
No head-to-head trials; mechanistic support |
|
Best for |
Anxiety-driven insomnia; pain-disrupted sleep; sleep maintenance |
GABA-deficient insomnia; primary sleep onset difficulty; mild sedative need |
Comprehensive — anxiety + GABA both addressed |
|
Sleep Problem |
Best Choice |
Why |
|
Anxiety-driven — can't quiet the mind |
CBD (primary) |
5-HT1A mechanism directly targets anxious hyperarousal; valerian's GABA effect is less targeted |
|
Can't fall asleep — general sleepiness deficit |
Valerian (primary) + CBD (add-on) |
Valerian's direct sedative GABA activity addresses primary sleepiness; CBD adds anxiety support |
|
Waking in the night / maintenance insomnia |
CBD (primary) + Valerian (support) |
CBD's cortisol modulation reduces stress-triggered micro-arousals; valerian supports deeper initial sleep |
|
Pain preventing sleep |
CBD only |
CBD's analgesic properties address root cause; valerian has no pain-reducing mechanism |
|
Stress and work overload insomnia |
CBD (primary) + Magnesium (better pairing) |
For stress-driven insomnia, CBD + magnesium covers cortisol + GABA more cleanly than CBD + valerian |
|
General insomnia without clear driver |
CBD+CBN Sleep Gummies (try first) |
CBD+CBN covers anxiety and mild sedation; add valerian if additional GABA support needed |
|
Next-morning grogginess from other sedatives |
CBD only |
Valerian adds sedative burden; CBD is non-sedating and may improve morning clarity |
|
Seniors / medication users |
CBD (primary; valerian with physician OK) |
Valerian's sedative interactions warrant physician review for older adults on multiple medications |
Yes — with appropriate awareness. CBD and valerian are frequently taken together, and there is no known direct negative pharmacodynamic interaction. However, there are considerations:
A sensible stacking approach if combining:TakePureCraft's CBD+CBN Sleep Gummies 30–45 minutes before bed. Add 300–450mg of standardized valerian extract only if CBD alone isn't providing adequate sleep onset. Start with a lower valerian dose when stacking and assess grogginess the following morning before increasing. Consider the magnesium glycinate addition (from Blog 8) as an alternative to valerian if grogginess is a concern — magnesium provides GABA support without the sedation risk.
PureCraft'sCBD+CBN Sleep Gummies include CBN — cannabinol — which has its own established sedative properties, distinct from CBD. CBN's sedative mechanism involves CB1 receptor activity in sleep circuits, GABA-A interaction, and possible antihistamine-like activity. For many users, the CBD+CBN combination already provides the gentle sedative push toward sleep that they might otherwise seek from valerian — without the grogginess risk.
This means the real question for most CBD+CBN users considering valerian is: do I have a sleep problem that isn't being addressed by CBD+CBN? If the answer is yes — particularly if physical GABA-deficient sedation rather than anxiety is the primary driver — valerian is a reasonable add-on. If CBD+CBN is mostly working, adding valerian introduces the grogginess variable without clear incremental benefit.
For most people with anxiety-driven or stress-related insomnia — which represents the majority of chronic insomnia cases in modern adults — CBD produces more consistent results with a cleaner side effect profile. Valerian's GABA-direct sedation is more useful for people whose sleep difficulty is primarily about a deficit of sedation rather than excess anxiety. The 'racing thoughts at bedtime' profile points to CBD; the 'just can't get drowsy' profile points more to valerian.
It can — particularly at higher doses or in people who are sensitive to its sedating effects. This is valerian's primary practical disadvantage compared to CBD. The grogginess typically reflects residual GABA enhancement and usually resolves with lower doses or by taking it earlier in the evening. CBD at typical wellness doses does not produce morning grogginess.
Onset is highly variable — anywhere from 30 minutes to 2 hours. This variability is one of valerian's practical limitations. Some people also report that consistent nightly use for 2–4 weeks produces better results than a single dose, suggesting cumulative effects similar to CBD.
Yes — the combination is generally safe and well-tolerated for most healthy adults. Start with the lower end of each dose when first combining. If you are on any sedative medications, antidepressants, or benzodiazepines, discuss the combination with your physician before starting. Consider whetherCBD+CBN Sleep Gummies alone (with the CBN sedative component already included) might provide what you're looking for without adding valerian.
Valerian has been used medicinally for centuries with a good safety record. Long-term use studies are limited, but available evidence doesn't indicate significant safety concerns for typical doses in healthy adults. Unlike benzodiazepines, valerian doesn't cause clinically significant physical dependence or tolerance escalation — though gradual discontinuation after prolonged high-dose use is prudent.
CBD wins as the default choice for most sleep problems — particularly anxiety-driven insomnia, which is the most prevalent sleep pattern in modern adults. It has more consistent clinical evidence, no grogginess risk, broader mechanism coverage (anxiety, cortisol, pain, ECS circadian support), and no sedative drug interaction concerns at typical doses.
Valerian has a specific role: direct GABA-mediated sedation for people whose sleep difficulty is primarily about not being drowsy enough — rather than being too anxious. For that specific profile, valerian genuinely adds something CBD doesn't provide as directly. But for many users, the CBN component in PureCraft's sleep gummies already covers that role without the grogginess variable valerian introduces.
When in doubt, start with CBD+CBN. Add valerian only if CBD+CBN alone isn't producing adequate sleep onset improvement after two to three weeks.
Start withPureCraft's CBD+CBN Sleep Gummies — nano-optimized, zero THC, third-party tested, USA-grown hemp. The CBD+CBN combination covers both the anxiety and the mild sedation dimensions, without the grogginess risk that valerian introduces.
Medical Disclaimer | This article is for informational and educational purposes only and does not constitute medical advice. Neither CBD nor valerian root is a treatment for diagnosed insomnia disorder or sleep apnea. Persistent sleep problems should be evaluated by a physician. The FDA has not evaluated these statements. People taking sedative medications, benzodiazepines, or other central nervous system depressants should not combine CBD or valerian without physician guidance. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.
Medical Disclaimer | Sauna use is contraindicated in certain cardiovascular conditions, pregnancy, and with medications that impair heat tolerance...
Read More
Medical Disclaimer | Cold water immersion is contraindicated in people with cardiovascular conditions, Raynaud's disease, hypertension, or cold ur...
Read More
Medical Disclaimer | This article is for informational and educational purposes only. Intermittent fasting and CBD supplementation should be appro...
Read More